Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROGEST: Progesterone for Vasomotor Symptoms
NCT03202186Phase 3Terminated
- Sponsor
- BHR Pharmaceuticals
- Start
- Aug 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of progesterone in vasomotor symptoms, sponsored by BHR Pharmaceuticals. Started Aug 2017; status: terminated.
02
Drugs
progesterone
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT03202186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03202186.